Principal Financial Group’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.85M Sell
2025
Q1
$2.82M Buy
2024
Q4
$3.42M Buy
2024
Q3
$3.93M Buy
2024
Q2
$132K Sell
2024
Q1
$209K Buy
2023
Q4
$236K Sell
2023
Q3
$170K Buy
2023
Q2
$258K Buy
2023
Q1
$255K Sell
2022
Q4
$296K Buy